ArticleJournal of experimental & clinical cancer research : CR2018

MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.

Guangbing Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.